These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19675265)

  • 21. Glycemic Targets in Diabetes Care: Emerging Clarity after Accord.
    Buse JB
    Trans Am Clin Climatol Assoc; 2015; 126():62-76. PubMed ID: 26330660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Hypoglycemia in Cardiovascular Outcomes in Diabetes.
    Paty BW
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S155-9. PubMed ID: 26654859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Questions for practicing internists].
    Zinnenlauf S
    Praxis (Bern 1994); 2008 Aug; 97(17):945-6. PubMed ID: 18777778
    [No Abstract]   [Full Text] [Related]  

  • 24. Is glycemic control a quinidine-like intervention?
    Bloomgarden ZT
    J Diabetes; 2014 Sep; 6(5):387-8. PubMed ID: 24842383
    [No Abstract]   [Full Text] [Related]  

  • 25. Intensive Glycemic Control in Type 2 Diabetes Mellitus -- A Balancing Act of Latent Benefit and Avoidable Harm: A Teachable Moment.
    Rodriguez-Gutierrez R; Lipska KJ; McCoy RG
    JAMA Intern Med; 2016 Mar; 176(3):300-1. PubMed ID: 26882223
    [No Abstract]   [Full Text] [Related]  

  • 26. The management of type 2 diabetes mellitus: a novel approach for addressing glycemic and lipid control with colesevelam HCl.
    Wright WL
    Adv Nurse Pract; 2009 Nov; 17(11):suppl 1-16. PubMed ID: 20014684
    [No Abstract]   [Full Text] [Related]  

  • 27. What matters in ADVANCE and ADVANCE-ON.
    Hamet P
    Diabetes Obes Metab; 2012 Jan; 14 Suppl 1():20-9. PubMed ID: 22118707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of glycemic control in diabetes in the CVOT era.
    Einhorn D
    J Diabetes; 2020 Jan; 12(1):4. PubMed ID: 31746129
    [No Abstract]   [Full Text] [Related]  

  • 29. Diabetes and Cardiovascular Disease: Is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR.
    Schernthaner G
    Wien Med Wochenschr; 2010 Jan; 160(1-2):8-19. PubMed ID: 20229156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decrease mortality in type II diabetes mellitus: glycemic and renal function control.
    Borghi C; Ventura F
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e13-e15. PubMed ID: 29538138
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of type 2 diabetes: more evidence is required to address the clinical and contextual facets.
    Hernandez-Jimenez S; Aguilar-Salinas CA; Mehta R; Rull JA; Gómez-Pérez FJ
    Curr Diabetes Rev; 2011 Mar; 7(2):99-105. PubMed ID: 21294708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does intensive therapy of type 2 diabetes help or harm? Seeking accord on ACCORD.
    Hoogwerf BJ; ;
    Cleve Clin J Med; 2008 Oct; 75(10):729-37. PubMed ID: 18939389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guidelines ease up on glycemic control for some patients with type 2 diabetes.
    Mitka M
    JAMA; 2012 Jun; 307(21):2243-4. PubMed ID: 22706812
    [No Abstract]   [Full Text] [Related]  

  • 34. Aggressive glycemic control might not be best choice for all diabetic patients.
    Mitka M
    JAMA; 2010 Mar; 303(12):1137-8. PubMed ID: 20332394
    [No Abstract]   [Full Text] [Related]  

  • 35. Patient-Centered Guidelines for Geriatric Diabetes Care: Potential Missed Opportunities to Avoid Harm.
    McCreedy EM; Kane RL; Gollust SE; Shippee ND; Clark KD
    J Am Board Fam Med; 2018; 31(2):192-200. PubMed ID: 29535235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes Mellitus.
    Kirkman MS; Mahmud H; Korytkowski MT
    Endocrinol Metab Clin North Am; 2018 Mar; 47(1):81-96. PubMed ID: 29407058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of insulin glargine U-300 versus insulin glargine U-100 on nocturnal hypoglycemia and glycemic control in type 1 and type 2 diabetes: a systematic review and meta-analysis.
    Díez-Fernández A; Cavero-Redondo I; Moreno-Fernández J; Pozuelo-Carrascosa DP; Garrido-Miguel M; Martínez-Vizcaíno V
    Acta Diabetol; 2019 Mar; 56(3):355-364. PubMed ID: 30506484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT.
    Terry T; Raravikar K; Chokrungvaranon N; Reaven PD
    Curr Cardiol Rep; 2012 Feb; 14(1):79-88. PubMed ID: 22160862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Need to Change Regulatory Evaluation of Hypoglycemia in Trials of Diabetes Treatments.
    Klonoff DC; Fleming A; Gabbay R
    J Diabetes Sci Technol; 2020 Nov; 14(6):987-989. PubMed ID: 31744326
    [No Abstract]   [Full Text] [Related]  

  • 40. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial--clinical implications.
    Ismail-Beigi F
    Clin Chem; 2011 Feb; 57(2):261-3. PubMed ID: 20974799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.